CHINGCHENG ATTORNEYS AT LAW-law firm,lawyer
Close
Team Intro
Team Intro
About Us
Attorneys
Intellectual property research
Expertise & Services
Expertise & Services
Key Clients
Key Clients
Articles
Articles
Taiwan Know-How
Real-Time Upda
Patent analysis
Contact Us
Contact Us
Articles
首頁
> Articles
Article
Taiwan Know-How for Foreigners
Real-Time Update
Patent analysis opinions
UCB’s “Zilucoplan” has been approved for marketing in China
release:2025/10/21
FDA Approves the World’s First PDE4B Inhibitor Nerandomilast for Idiopathic Pulmonary Fibrosis
release:2025/10/21
AT&T and Nokia Win Patent Infringement Lawsuit
release:2025/10/21
Understanding Your Labor Rights in Taiwan as a Foreign Employee
release:2025/10/18
InnoCare’s “Orelabrutinib” has been approved in Singapore
release:2025/09/29
xAI Wins Court Order Blocking Former Engineer from Sharing AI Technology with OpenAI
release:2025/09/29
Novartis Atrasentan Hydrochloride Tablets Approved in China
release:2025/09/29
Foreign Professionals in Taiwan: Essential Guide to Labor Insurance Enrollment
release:2025/09/18
Labor Insurance for Foreign Professionals Working in Taiwan
NT$10,000 Cash Handouts: Are Foreigners Eligible?
release:2025/09/16
The world’s first generic Dulaglutide has been approved for marketing in China
release:2025/09/07
Bayer Submits NDA for HER2-Targeted Therapy BAY 2927088 in China
release:2025/09/07
SUN PHARMA LAUNCHES HAIR LOSS DRUG IN THE UNITED STATES AFTER PATENT DISPUTE SETTLEMENT WITH INCYTE
release:2025/09/07
1
2
3
4
5
6
7
8
9
TOP
回首頁
電話